Nasdaq IPOs

Marpai, a pre-revenue managed health plan platform for self-insured employers, filed on Tuesday with the SEC to raise up to $31 million in an initial public offering. Marpai aims to create the healthcare payer of the future for self-insured employers by using artificial intellig

Clarios International, a global manufacturer of low-voltage vehicle batteries, announced terms for its IPO on Tuesday.The Milwaukee, WI-based company plans to raise $1.7 billion by offering 88.1 million shares at a price range of $17 to $21. The Sponsor intends to purchase $500 m

Chavant Capital Acquisition, a blank check company targeting advanced manufacturing and materials technology, raised $80 million by offering 8 million units at $10. The company offered 2 million fewer units than anticipated. Each unit contains one share of common stock and t

TortoiseEcofin Acquisition III, the third blank check company led by Vincent Cubbage targeting the energy transition and sustainability arena, raised $300 million by offering 30 million units at $10. Each unit consists of one ordinary share and one-fourth of a warrant, exercisabl

Clover Leaf Capital, a blank check company backed by Yntegra Group targeting the cannabis industry, raised $125 million by offering 12.5 million units at $10. Each unit consists of one share of common stock and one right to receive one-eighth of a share upon the consummation of t

HCW Biologics, a Phase 2 biotech developing novel immunotherapies for cancer, raised $56 million by offering 7.0 million shares at $8, the low end of the range of $8 to $10. The company had originally planned to raise $50 million, but upsized the share offering by 25%. Directors

Seaport Calibre Materials Acquisition, a blank check company formed by SGAM and Calibre Group targeting the steel, metals, and metal processing sector, filed on Monday with the SEC to raise up to $150 million.The New York, NY-based company plans to raise $150 million by offering

Dynacure, a French Phase 1/2 biotech developing therapies for neuromuscular diseases, withdrew its plans for an initial public offering on Monday, following its postponement last week. It had filed to raise $100 million by offering 6.3 million shares at a price range of $15 to $1

Aesther Healthcare Acquisition, a blank check company led by TRxADE Health executives targeting the pharma and medical device sectors, filed on Monday with the SEC to raise up to $100 million.The New York, NY-based company plans to raise $100 million by offering 10 million units

There has been lots of speculation around a potential initial public offering (IPO) from Klarna, which according to TechCrunch is the highest valued private fintech in Europe.

Oxbridge Acquisition, a blank check company targeting insurance technology and blockchain, filed on Monday with the SEC to raise up to $100 million. The Cayman Islands-based company plans to raise $100 million by offering 10 million units at $10. Each unit consists of one share

Kensington Capital Acquisition V, a blank check company led by the founder of Kensington Capital targeting industrials, filed on Monday with the SEC to raise up to $260 million.The Westbury, NY-based company plans to raise $260 million by offering 26 million units at $10. Each un

MeridianLink, which provides cloud-based software solutions for financial institutions, announced terms for its IPO on Monday.The Costa Mesa, CA-based company plans to raise $300 million by offering 12 million shares (17% secondary) at a price range of $24 to $26. New investor Da

Riskified, which provides e-commerce fraud protection for enterprises, announced terms for its IPO on Monday. The Tel Aviv, Israel-based company plans to raise $333 million by offering 17.5 million shares (1% insider) at a price range of $18 to $20. At the midpoint of the propos

SOPHiA GENETICS, which provides a data-driven SaaS platform for the healthcare industry, announced terms for its IPO on Monday.The Saint-Sulpice, Switzerland-based company plans to raise $234 million by offering 13 million shares at a price range of $17 to $19. The company plans

Cytek BioSciences, which provides cell analysis instruments for life science applications, announced terms for its IPO on Monday. The Fremont, CA-based company plans to raise $248 million by offering 14.6 million shares (19% insider) at a price range of $16 to $18. At the midpoi

Dole, a leading global branded fruit and vegetable company, announced terms for its IPO on Monday.The Dublin, Ireland-based company plans to raise $559 million by offering 26 million shares (9% secondary) at a price range of $20 to $23. At the midpoint of the proposed range, Dole

Caribou Biosciences, a Phase 1 biotech developing gene edited cell therapies for multiple cancers, announced terms for its IPO on Monday. The Berkeley, CA-based company plans to raise $203 million by offering 13.5 million shares at a price range of $14 to $16. At the midpoint of

Robinhood Markets, a fast growing no-fee stock trading app, announced terms for its IPO on Monday.The Menlo Park, CA-based company plans to raise $2.2 billion by offering 55 million shares (5% secondary) at a price range of $38 to $42. New investor Salesforce has indicated on up

Cognition Therapeutics, a Phase 2 biotech developing small molecule therapies for Alzheimer's and other CNS diseases, filed on Monday with the SEC to raise up to $50 million in an initial public offering. Cognition Therapeutics is developing small molecule therapies for age-rela